✦ LIBER ✦

Omalizumab, an anti-IgE antibody, significantly reduces emergency visits in patients with severe persistent asthma: A pooled analysis

✍ Scribed by Korenblat, P.; Meltzer, E.; Busse, W.; Hedgecock, S.; Fox, H.; Blogg, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Omalizumab significantly reduces asthma

✍ Berger, W.; Ostrom, N.; Soler, M.; Hedgecock, S.; Fox, H.; Blogg, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 29 KB

The effect of treatment with omalizumab,

✍ J. Bousquet; P. Cabrera; N. Berkman; R. Buhl; S. Holgate; S. Wenzel; H. Fox; S. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Omalizumab, a recombinant humanized anti

✍ Corren, Jonathan; Casale, Thomas; Deniz, Yamo; Ashby, Mark 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Efficacy of omalizumab, an anti-IgE anti

✍ DAHL, R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Omalizumab, an Anti-IgE Monoclonal Antib

✍ Hébert, J.; Rolli, M.; Gao, J.; Reisner, C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Omalizumab, an anti-IgE antibody, improv

✍ HARNEST, U 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB